nach oben

Erschienen in:

04.10.2017 | Review Article

Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach

verfasst von: Antonino Catalano, Gabriella Martino, Nunziata Morabito, Claudia Scarcella, Agostino Gaudio, Giorgio Basile, Antonino Lasco

Erschienen in: Drugs & Aging | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Abstract

The high worldwide prevalence of osteoporosis means it is considered a serious public health concern, possibly leading to physical disability and an increased mortality rate. Although osteoporosis is known as a silent disease affecting aging populations, its primary symptom remains pain. Acute pain is reported by patients with osteoporosis-related fractures, but chronic pain, mainly back pain, is also a characteristic of severe osteoporosis. Pain is associated not only with fractures but also with bodily changes in patients with osteoporosis that may include sensory, affective, and cognitive aspects. Chronic pain leads to progressive loss of independence and the need for long-term care, especially in the elderly. Pain prevention is linked to the appropriate treatment of osteoporosis, and pain management in patients with osteoporosis requires a multidimensional approach to preserve and improve quality of life. Our aim was to review and discuss the main causes of pain in patients with osteoporosis and suggest possible strategies for its management and prevention.

Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ 3rd, Khaltaev N. A reference standard for the description of osteoporosis. Bone. 2008;42(3):467–75.CrossRefPubMed

Tarantino U, Capone A, Planta M, D’Arienzo M, Letizia Mauro G, Impagliazzo A, Formica A, Pallotta F, Patella V, Spinarelli A, Pazzaglia U, Zarattini G, Roselli M, Montanari G, Sessa G, Privitera M, Verdoia C, Corradini C, Feola M, Padolino A, Saturnino L, Scialdoni A, Rao C, Iolascon G, Brandi ML, Piscitelli P. The incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: results from a 3-year multicenter study. Arthritis Res Ther. 2010;12(6):R226.CrossRefPubMedPubMedCentral

Svedbom A, Hernlund E, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA, EU Review Panel of IOF. Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteoporos. 2013;8:137.CrossRefPubMedPubMedCentral

O’Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ. The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res. 1996;11(7):1010–8.CrossRefPubMed

Kaptoge S, Armbrecht G, Felsenberg D, Lunt M, O’Neill TW, Silman AJ, Reeve J, EPOS Study Group. When should the doctor order a spine X-ray? Identifying vertebral fractures for osteoporosis care: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res. 2004;19(12):1982–93.CrossRefPubMed

Ismail AA, Cockerill W, Cooper C, Finn JD, Abendroth K, Parisi G, Banzer D, Benevolenskaya LI, Bhalla AK, Armas JB, Cannata JB, Delmas PD, Dequeker J, Dilsen G, Eastell R, Ershova O, Falch JA, Felsch B, Havelka S, Hoszowski K, Jajic I, Kragl U, Johnell O, Lopez Vaz A, Lorenc R, Lyritis G, Marchand F, Masaryk P, Matthis C, Miazgowski T, Pols HA, Poor G, Rapado A, Raspe HH, Reid DM, Reisinger W, Janott J, Scheidt-Nave C, Stepan J, Todd C, Weber K, Woolf AD, Ambrecht G, Gowin W, Felsenberg D, Lunt M, Kanis JA, Reeve J, Silman AJ, O’Neill TW. Prevalent vertebral deformity predicts incident hip though not distal forearm fracture: results from the European Prospective Osteoporosis Study. Osteoporos Int. 2001;12(2):85–90.CrossRefPubMed

Tarantino U, Baldi J, Celi M, Rao C, Liuni FM, Iundusi R, Gasbarra E. Osteoporosis and sarcopenia: the connections. Aging Clin Exp Res. 2013;25(Suppl 1):S93–5.CrossRefPubMed

Sinaki M, Brey RH, Hughes CA, Larson DR, Kaufman KR. Balance disorder and increased risk of falls in osteoporosis and kyphosis: significance of kyphotic posture and muscle strength. Osteoporos Int. 2005;16(8):1004–10.CrossRefPubMed

Kim DH, Vaccaro AR. Osteoporotic compression fractures of the spine; current options and considerations for treatment. Spine J. 2006;6(5):479–87.CrossRefPubMed

10.

Iolascon G, Gimigliano F, Malavolta N, Tarantino U, Fornari R, Greco E, Di Pietro G, Gimigliano R, Lenzi A, Resmini G, Migliaccio S. Effectiveness of teriparatide treatment on back pain-related functional limitations in individuals affected by severe osteoporosis: a prospective pilot study. Clin Cases Miner Bone Metab. 2012;9(3):161–5.PubMedPubMedCentral

11.

Nagae M, Hiraga T, Wakabayashi H, Wang L, Iwata K, Yoneda T. Osteoclasts play a part in pain due to the inflammation adjacent to bone. Bone. 2006;39(5):1107–15.CrossRefPubMed

12.

Catalano A, Morabito N, Basile G, Fusco S, Castagna G, Reitano F, Albanese RC, Lasco A. Fracture risk assessment in postmenopausal women referred to an Italian center for osteoporosis: a single day experience in Messina. Clin Cases Miner Bone Metab. 2013;10(3):191–4.PubMed

13.

IASP. Classification of chronic pain. Pain. 1986;3:S1–226.

14.

Iannetti GD, Mouraux A. From the neuromatrix to the pain matrix (and back). Exp Brain Res. 2010;205(1):112.CrossRef

15.

Craig AD. How do you feel now? The anterior insula and human awareness. Nat Rev Neurosci. 2009;10(1):59–70.CrossRefPubMed

16.

Tsang A, Von Korff M, Lee S, Alonso J, Karam E, Angermeyer MC, Borges GL, Bromet EJ, Demytteneare K, de Girolamo G, de Graaf R, Gureje O, Lepine JP, Haro JM, Levinson D, Oakley Browne MA, Posada-Villa J, Seedat S, Watanabe M. Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders. J Pain. 2008;9(10):883–91.CrossRefPubMed

17.

Turk DC, Rudy TE. The robustness of an empirically derived taxonomy of chronic pain patients. Pain. 1990;43(1):27–35.CrossRefPubMed

18.

Smart KM, Blake C, Staines A, Doody C. The Discriminative validity of “nociceptive,” “peripheral neuropathic,” and “central sensitization” as mechanisms-based classifications of musculoskeletal pain. Clin J Pain. 2011;27(8):655–63.CrossRefPubMed

19.

Haviv B, Bronak S, Thein R. The complexity of pain around the knee in patients with osteoarthritis. Isr Med Assoc J. 2013;15(4):178–81.PubMed

20.

Mediati R, Vellucci R, Dodaro L. Pathogenesis and clinical aspects of pain in patients with osteoporosis. Clin Cases Miner Bone Metab. 2014;11(3):169–72.PubMedPubMedCentral

21.

Kasperk C, Hillmeier J, Nöldge G, Grafe IA, Dafonseca K, Raupp D, Bardenheuer H, Libicher M, Liegibel UM, Sommer U, Hilscher U, Pyerin W, Vetter M, Meinzer HP, Meeder PJ, Taylor RS, Nawroth P. Treatment of painful vertebral fractures by kyphoplasty in patients with primary osteoporosis: a prospective non-randomized controlled study. J Bone Miner Res. 2005;20(4):604–12.CrossRefPubMed

22.

Langdahl BL, Rajzbaum G, Jakob F, Karras D, Ljunggren O, Lems WF, Fahrleitner-Pammer A, Walsh JB, Barker C, Kutahov A, Marin F. Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS). Calcif Tissue Int. 2009;85(6):484–93.CrossRefPubMedPubMedCentral

23.

Arora R, Gabl M, Gschwentner M, Deml C, Krappinger D, Lutz M. A comparative study of clinical and radiologic outcomes of unstable colles type distal radius fractures in patients older than 70 years: non operative treatment versus volar locking plating. J Orthop Trauma. 2009;23:237–42.CrossRefPubMed

24.

Bartl C, Stengel D, Bruckner T. Gebhard F and the ORCHID Study Group: The treatment of displaced intra-articular distal radius fractures in elderly patients-a randomized multi-center study (ORCHID) of open reduction and volar locking plate fixation versus closed reduction and cast immobilization. Dtsch Arztebl Int. 2014;111:779–87.PubMedPubMedCentral

25.

Rangan A, Handoll H, Brealey S, Jefferson L, Keding A, Martin BC, Goodchild L, Chuang LH, Hewitt C, Torgerson D, PROFHER Trial Collaborators. Surgical vs nonsurgical treatment of adults with displaced fractures of the proximal humerus: the PROFHER randomized clinical trial. JAMA. 2015;313(10):1037–47.CrossRefPubMed

26.

Alesci S, Martinez PE, Kelkar S, Ilias I, Ronsaville DS, Listwak SJ, Ayala AR, Licinio J, Gold HK, Kling MA, Chrousos GP, Gold PW. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab. 2005;90(5):2522–30.CrossRefPubMed

27.

Atteritano M, Lasco A, Mazzaferro S, Macrì I, Catalano A, Santangelo A, Bagnato G, Bagnato G, Frisina N. Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression. Intern Emerg Med. 2013;8(6):485–91.CrossRefPubMed

28.

Dziechciaż M, Balicka-Adamik L, Filip R. The problem of pain in old age. Ann Agric Environ Med. 2013;1:35–8.

29.

Julius D, Basbaum Al. Molecular mechanisms of nociception. Nature. 2001;413:203–10.CrossRefPubMed

30.

Consalvo M, Coluzzi F, Celidonio L, Vellucci R. Bone pain mechanism in osteoporosis: a narrative review. Clin Cases Miner Bone Metab. 2016;13(2):97–100.

31.

Abdelaziz DM, Abdullah S, Magnussen C, Ribeiro-da-Silva A, Komarova SV, Rauch F, Stone LS. Behavioral signs of pain and functional impairment in a mouse model of osteogenesis imperfecta. Bone. 2015;81:400–6.CrossRefPubMed

32.

Liu H, Mantyh PW, Basbaum AI. NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature. 1997;386(6626):721–4.CrossRefPubMed

33.

Pinto-Ribeiro F, Moreira V, Pego JM, Leao P, Almeida A, Sousa N. Anti-nociception induced by chronic glucocorticoid treatment is correlated to local modulation of spinal neurotransmitter content. Mol Pain. 2009;5:41.CrossRefPubMedPubMedCentral

34.

Yamamotova A, Bulant J, Bocek V, Papezova H. Dissatisfaction with own body makes patients with eating disorders more sensitive to pain. J Pain Res. 2017;10:1667–75.CrossRefPubMedPubMedCentral

35.

Lange U, Teichmann J, Uhlemann C. Current knowledge about physiotherapeutic strategies in osteoporosis prevention and treatment. Rheumatol Int. 2005;26(2):99–106.CrossRefPubMed

36.

Angın E, Erden Z, Can F. The effects of clinical pilates exercises on bone mineral density (BMD), physical performance and quality of life of women with postmenopausal osteoporosis. J Back Musculoskelet Rehabil. 2015;28(4):849–58.CrossRefPubMed

37.

Bautmans I, Van Arken J, Van Mackelenberg M, Mets T. Rehabilitation using manual mobilization for thoracic kyphosis in elderly postmenopausal patients with osteoporosis. J Rehabil Med. 2010;42(2):129–35.CrossRefPubMed

38.

Kriska AM, Bayles C, Cauley JA, LaPorte RE, Sandler RB, Pambianco G. A randomized exercise trial in older women: increased activity over two years and the factors associated with compliance. Med Sci Sports Exerc. 1986;18(5):557–62.CrossRefPubMed

39.

Gregg EW, Cauley JA, Seeley DG, Ensrud KE, Bauer DC. Physical activity and osteoporotic fracture risk in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med. 1998;129(2):81–8.CrossRefPubMed

40.

McCarthy J, Davis A. Diagnosis and management of vertebral compression fractures. Am Fam Physician. 2016;94(1):44–50.PubMed

41.

Lee CH, Lee TY, Her JS, Liao WL, Hsieh CL. Single-blinded, randomized preliminary study evaluating the effect of transcutaneous electrical nerve stimulation on postoperative pain in patients with Colles’ fracture. J Altern Complement Med. 2015;21(12):754–8.CrossRefPubMed

42.

Schiller J, Korallus C, Bethge M, Karst M, Schmalhofer ML, Gutenbrunner C, Fink MG. Effects of acupuncture on quality of life and pain in patients with osteoporosis—a pilot randomized controlled trial. Arch Osteoporos. 2016;11(1):34.CrossRefPubMed

43.

Mert T, Kurt AH, Altun İ, Celik A, Baran F, Gunay I. Pulsed magnetic field enhances therapeutic efficiency of mesenchymal stem cells in chronic neuropathic pain model. Bioelectromagnetics. 2017;38(4):255–64.CrossRefPubMed

44.

Bistolfi F. Extremely low-frequency pulsed magnetic fields and multiple sclerosis: effects on neurotransmission alone or also on immunomodulation? Building a working hypothesis. Neuroradiol J. 2007;20(6):676–93.CrossRefPubMed

45.

Reale M, Kamal MA, Patruno A, Costantini E, D’Angelo C, Pesce M, Greig NH. Neuronal cellular responses to extremely low frequency electromagnetic field exposure: implications regarding oxidative stress and neurodegeneration. PLoS One. 2014;9(8):e104973.CrossRefPubMedPubMedCentral

46.

Maestú C, Blanco M, Nevado A, Romero J, Rodríguez-Rubio P, Galindo J, Bautista Lorite J, de las Morenas F, Fernández-Argüelles P. Reduction of pain thresholds in fibromyalgia after very low-intensity magnetic stimulation: a double-blinded, randomized placebo-controlled clinical trial. Pain Res Manag. 2013;18:e101–6.CrossRefPubMedPubMedCentral

47.

Iwamoto J, Takeda T, Sato Y, Uzawa M. Effect of whole-body vibration exercise on lumbar bone mineral density, bone turnover, and chronic back pain in post-menopausal osteoporotic women treated with alendronate. Aging Clin Exp Res. 2005;17(2):157–63.CrossRefPubMed

48.

Ehde DM, Dillworth TM, Turner JA. Cognitive-behavioral therapy for individuals with chronic pain: efficacy, innovations, and directions for research. Am Psychol. 2014;69(2):153–66.CrossRefPubMed

49.

O’Connor JP, Lysz T. Celecoxib, NSAIDs and the skeleton. Drugs Today (Barc). 2008;44(9):693–709.CrossRefPubMed

50.

Adolphson P, Abbaszadegan H, Jonsson U, Dalén N, Sjöberg HE, Kalén S. No effects of piroxicam on osteopenia and recovery after Colles’ fracture. A randomized, double-blind, placebo-controlled, prospective trial. Arch Orthop Trauma Surg. 1993;112(3):127–30.CrossRefPubMed

51.

Davis TR, Ackroyd CE. Non-steroidal anti-inflammatory agents in the management of Colles’ fractures. Br J Clin Pract. 1988;42(5):184–9.PubMed

52.

Bauer DC, Orwoll ES, Fox KM, Vogt TM, Lane NE, Hochberg MC, Stone K, Nevitt MC. Aspirin and NSAID use in older women: effect on bone mineral density and fracture risk. Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1996;11(1):29–35.CrossRefPubMed

53.

Vellucci R, Consalvo M, Celidonio L, Mediati RD. Implications of analgesics use in osteoporotic-related pain treatment: focus on opioids. Clin Cases Miner Bone Metab. 2016;13(2):89–92.PubMedPubMedCentral

54.

Paolucci T, Saraceni VM, Piccinini G. Management of chronic pain in osteoporosis: challenges and solutions. J Pain Res. 2016;9:177–86.CrossRefPubMedPubMedCentral

55.

Sheedy KC, Camara MI, Camacho PM. Comparison of the efficacy, adverse effects, and cost of zoledronic acid and denosumab in the treatment of osteoporosis. Endocr Pract. 2015;21(3):275–9.CrossRefPubMed

56.

Kim S, Seiryu M, Okada S, Kuroishi T, Takano-Yamamoto T, Sugawara S, Endo Y. Analgesic effects of the non-nitrogen-containing bisphosphonates etidronate and clodronate, independent of anti-resorptive effects on bone. Eur J Pharmacol. 2013;699(1–3):14–22.CrossRefPubMed

57.

Songpatanasilp T, Mumtaz M, Chhabra H, Yu M, Sorsaburu S. Back pain in patients with severe osteoporosis on teriparatide or antiresorptives: a prospective observational study in a multiethnic population. Singap Med J. 2014;55(9):493–501.CrossRef

58.

Miller PD, Chines AA, Christiansen C, Hoeck HC, Kendler DL, Lewiecki EM, Woodson G, Levine AB, Constantine G, Delmas PD. Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study. J Bone Miner Res. 2008;23(4):525–35.CrossRefPubMed

59.

Marquis P, Roux C, de la Loge C, Diaz-Curiel M, Cormier C, Isaia G, Badurski J, Wark J, Meunier PJ. Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis. Osteoporos Int. 2008;19(4):503–10.CrossRefPubMed

60.

Morabito N, Catalano A, Gaudio A, Morini E, Bruno LM, Basile G, Tsiantouli E, Bellone F, Agostino RM, Piraino B, La Rosa MA, Salpietro C, Lasco A. Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis. J Bone Miner Metab. 2016;34(5):540–6.CrossRefPubMed

61.

Bruyere O, Delferriere D, Roux C, Wark JD, Spector T, Devogelaer JP, Brixen K, Adami S, Fechtenbaum J, Kolta S, Reginster JY. Effects of strontium ranelate on spinal osteoarthritis progression. Ann Rheum Dis. 2008;67(3):335–9.CrossRefPubMed

62.

Delmas PD. Clinical effects of strontium ranelate in women with postmenopausal osteoporosis. Osteoporos Int. 2005;16(Suppl 1):S16–9.CrossRefPubMed

63.

Langdahl BL, Ljunggren Ö, Benhamou CL, Marin F, Kapetanos G, Kocjan T, Lespessailles E, Napoli N, Nikolic T, Petto H, Moll T, Lindh E. Fracture rate, quality of life and back pain in patients with osteoporosis treated with teriparatide: 24-month results from the Extended Forsteo Observational Study (ExFOS). Calcif Tissue Int. 2016;99(3):259–71.CrossRefPubMedPubMedCentral

64.

Catalano A, Vita GL, Russo M, Vita G, Lasco A, Morabito N, Messina S. Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report. Osteoporos Int. 2016;27(12):3655–9.CrossRefPubMed

65.

Fahrleitner-Pammer A, Langdahl BL, Marin F, Jakob F, Karras D, Barrett A, Ljunggren Ö, Walsh JB, Rajzbaum G, Barker C, Lems WF. Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS). Osteoporos Int. 2011;22(10):2709–19.CrossRefPubMed

66.

Genant HK, Halse J, Briney WG, Xie L, Glass EV, Krege JH. The effects of teriparatide on the incidence of back pain in postmenopausal women with osteoporosis. Curr Med Res Opin. 2005;21(7):1027–34.CrossRefPubMed

67.

Catalano A, Morabito N, Atteritano M, Basile G, Cucinotta D, Lasco A. Vitamin D reduces musculoskeletal pain after infusion of zoledronic acid for postmenopausal osteoporosis. Calcif Tissue Int. 2012;90(4):279–85.CrossRefPubMed

68.

Lasco A, Catalano A, Benvenga S. Improvement of primary dysmenorrhea caused by a single oral dose of vitamin D: results of a randomized, double-blind, placebo-controlled study. Arch Intern Med. 2012;172(4):366–7.CrossRefPubMed

69.

Catalano A, Morabito N, Di Stefano A, Morini E, Basile G, Faraci B, Loddo S, Ientile R, Lasco A. Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate. J Endocrinol Invest. 2015;38(8):859–63.CrossRefPubMed

70.

Oteri G, Cicciù M, Peditto M, Catalano A, Loddo S, Pisano M, Lasco A. Does vitamin D3 have an impact on clinical and biochemical parameters related to third molar surgery. J Craniofac Surg. 2016;27(2):469–76.CrossRefPubMed

71.

Kotlarczyk MP, Perera S, Ferchak MA, Nace DA, Resnick NM, Greenspan SL. Vitamin D deficiency is associated with functional decline and falls in frail elderly women despite supplementation. Osteoporos Int. 2017;28(4):1347–53.CrossRefPubMed

72.

Yang LY, Wang XL, Zhou L, Fu Q. A systematic review and meta-analysis of randomized controlled trials of unilateral versus bilateral kyphoplasty for osteoporotic vertebral compression fractures. Pain Physician. 2013;16(4):277–90.PubMed

73.

Santiago FR, Abela AP, Alvarez LG, Osuna RM, García Mdel M. Pain and functional outcome after vertebroplasty and kyphoplasty. A comparative study. Eur J Radiol. 2010;75(2):e108–13.CrossRefPubMed

74.

Chen LX, Li YL, Ning GZ, Li Y, Wu QL, Guo JX, Shi HY, Wang XB, Zhou Y, Feng SQ. Comparative efficacy and tolerability of three treatments in old people with osteoporotic vertebral compression fracture: a network meta-analysis and systematic review. PLoS One. 2015;10(4):e0123153.CrossRefPubMedPubMedCentral

75.

Esses SI, McGuire R, Jenkins J, Finkelstein J, Woodard E, Watters WC 3rd, Goldberg MJ, Keith M, Turkelson CM, Wies JL, Sluka P, Boyer KM, Hitchcock K, Raymond L. American Academy of Orthopaedic Surgeons clinical practice guideline on: the treatment of osteoporotic spinal compression fractures. J Bone Joint Surg Am. 2011;93(20):1934–6.CrossRefPubMed

Titel: Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach
verfasst von: Antonino Catalano
Gabriella Martino
Nunziata Morabito
Claudia Scarcella
Agostino Gaudio
Giorgio Basile
Antonino Lasco
Publikationsdatum: 04.10.2017
Verlag: Springer International Publishing
Erschienen in: Drugs & Aging / Ausgabe 10/2017
Print ISSN: 1170-229X
Elektronische ISSN: 1179-1969
DOI: https://doi.org/10.1007/s40266-017-0492-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

23.04.2024 | Ablationstherapie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Demenzkranke durch Antipsychotika vielfach gefährdet

Drei Mythen bei der Antibiotikatherapie

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2017

Association Between Anticholinergic Drug Use and Health-Related Quality of Life in Community-Dwelling Older Adults

Drug-Induced Kidney Injury in the Elderly

The Effect of Computerized Physician Order Entry Template Modifications on the Administration of High-Risk Medications in Older Adults in the Emergency Department

Discontinuation of Preventive Medicines in Older People with Limited Life Expectancy: A Systematic Review

Post-transplant Viral Respiratory Infections in the Older Patient: Epidemiology, Diagnosis, and Management

Repeat Adverse Drug Reaction-Related Hospital Admissions in Elderly Australians: A Retrospective Study at the Royal Hobart Hospital

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Demenzkranke durch Antipsychotika vielfach gefährdet

Drei Mythen bei der Antibiotikatherapie

Update Innere Medizin